MAIA Biotechnology, Inc. (MAIA)

USD 1.46

(-2.61%)

Total Assets Summary of MAIA Biotechnology, Inc.

  • MAIA Biotechnology, Inc.'s latest annual total assets in 2023 was 7.56 Million USD , down -37.06% from previous year.
  • MAIA Biotechnology, Inc.'s latest quarterly total assets in 2024 Q2 was 12.01 Million USD , up 37.9% from previous quarter.
  • MAIA Biotechnology, Inc. reported annual total assets of 12.02 Million USD in 2022, up 6.13% from previous year.
  • MAIA Biotechnology, Inc. reported annual total assets of 11.32 Million USD in 2021, up 1417.36% from previous year.
  • MAIA Biotechnology, Inc. reported quarterly total assets of 12.01 Million USD for 2024 Q2, up 37.9% from previous quarter.
  • MAIA Biotechnology, Inc. reported quarterly total assets of 10.26 Million USD for 2023 Q2, up 13.17% from previous quarter.

Annual Total Assets Chart of MAIA Biotechnology, Inc. (2023 - 2019)

Historical Annual Total Assets of MAIA Biotechnology, Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 7.56 Million USD -37.06%
2022 12.02 Million USD 6.13%
2021 11.32 Million USD 1417.36%
2020 746.5 Thousand USD -56.96%
2019 1.73 Million USD 0.0%

Peer Total Assets Comparison of MAIA Biotechnology, Inc.

Name Total Assets Total Assets Difference
AIM ImmunoTech Inc. 19.38 Million USD 60.957%
Ampio Pharmaceuticals, Inc. 5.73 Million USD -31.919%
Armata Pharmaceuticals, Inc. 109.96 Million USD 93.119%
Actinium Pharmaceuticals, Inc. 81.44 Million USD 90.709%
Azitra, Inc. 5.11 Million USD -47.92%
Can-Fite BioPharma Ltd. 9.98 Million USD 24.248%
Chromocell Therapeutics Corporation 96.39 Thousand USD -7750.164%
Calidi Biotherapeutics, Inc. 10.01 Million USD 24.475%
CEL-SCI Corporation 30.52 Million USD 75.214%
iBio, Inc. 28.73 Million USD 73.666%
Lineage Cell Therapeutics, Inc. 101.01 Million USD 92.509%
Matinas BioPharma Holdings, Inc. 65.57 Million USD 88.461%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD -73.091%
NovaBay Pharmaceuticals, Inc. 9.03 Million USD 16.24%
NanoViricides, Inc. 12.82 Million USD 40.989%
Oragenics, Inc. 4.96 Million USD -52.363%
BiomX Inc. 58.15 Million USD 86.989%
BiomX Inc. 58.15 Million USD 86.989%
Protalix BioTherapeutics, Inc. 84.43 Million USD 91.038%
Palatin Technologies, Inc. 10.74 Million USD 29.56%
Scorpius Holdings, Inc. 51.03 Million USD 85.174%
Theriva Biologics, Inc. 60.21 Million USD 87.433%